Al Namat, R.; Duceac, L.D.; Chelaru, L.; Dabija, M.G.; Guțu, C.; Marcu, C.; Popa, M.V.; Popa, F.; Bogdan Goroftei, E.R.; Țarcă, E.
Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis. Diagnostics 2024, 14, 16.
https://doi.org/10.3390/diagnostics14010016
AMA Style
Al Namat R, Duceac LD, Chelaru L, Dabija MG, Guțu C, Marcu C, Popa MV, Popa F, Bogdan Goroftei ER, Țarcă E.
Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis. Diagnostics. 2024; 14(1):16.
https://doi.org/10.3390/diagnostics14010016
Chicago/Turabian Style
Al Namat, Razan, Letiția Doina Duceac, Liliana Chelaru, Marius Gabriel Dabija, Cristian Guțu, Constantin Marcu, Maria Valentina Popa, Florina Popa, Elena Roxana Bogdan Goroftei, and Elena Țarcă.
2024. "Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis" Diagnostics 14, no. 1: 16.
https://doi.org/10.3390/diagnostics14010016
APA Style
Al Namat, R., Duceac, L. D., Chelaru, L., Dabija, M. G., Guțu, C., Marcu, C., Popa, M. V., Popa, F., Bogdan Goroftei, E. R., & Țarcă, E.
(2024). Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis. Diagnostics, 14(1), 16.
https://doi.org/10.3390/diagnostics14010016